Biotechnology in Canada

Date: February 12, 2015
Pages: 36
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B2DE6A6EBC4EN
Leaflet:

Download PDF Leaflet

Biotechnology in Canada
INTRODUCTION

Biotechnology in Canada industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Canada biotechnology market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

HIGHLIGHTS
  • The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
  • The Canadian biotechnology industry had total revenues of $3.8bn in 2014, representing a compound annual growth rate (CAGR) of 6.8% between 2010 and 2014.
  • The medical/healthcare segment was the industry's most lucrative in 2014, with total revenues of $2.6bn, equivalent to 66.7% of the industry's overall value.
  • The performance of the industry is forecast to decelerate, with an anticipated CAGR of 6.4% for the five-year period 2014 - 2019, which is expected to drive the industry to a value of $5.2bn by the end of 2019.
FEATURES
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the biotechnology market in Canada
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Canada
  • Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Canada biotechnology market with five year forecasts
  • Macroeconomic indicators provide insight into general trends within the Canada economy
KEY QUESTIONS ANSWERED
  • What was the size of the Canada biotechnology market by value in 2014?
  • What will be the size of the Canada biotechnology market in 2019?
  • What factors are affecting the strength of competition in the Canada biotechnology market?
  • How has the market performed over the last five years?
Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Amgen, Inc.
Baxter International Inc.
Covance Inc.
Novartis AG
Macroeconomic Indicators
Country Data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table: Canada biotechnology industry value: $ billion(e)
Table: Canada biotechnology industry category segmentation: $ billion, (e)
Table: Canada biotechnology industry geography segmentation: $ billion, (e)
Table: Canada biotechnology industry value forecast: $ billion
Table: Amgen, Inc.: key facts
Table: Amgen, Inc.: key financials ($)
Table: Amgen, Inc.: key financial ratios
Table: Baxter International Inc.: key facts
Table: Baxter International Inc.: key financials ($)
Table: Baxter International Inc.: key financial ratios
Table: Covance Inc.: key facts
Table: Covance Inc.: key financials ($)
Table: Covance Inc.: key financial ratios
Table: Novartis AG: key facts
Table: Novartis AG: key financials ($)
Table: Novartis AG: key financial ratios
Table: Canada size of population (million)
Table: Canada gdp (constant prices, $ billion)
Table: Canada gdp (current prices, $ billion)
Table: Canada inflation
Table: Canada consumer price index (absolute)
Table: Canada exchange rate

LIST OF FIGURES

Figure: Canada biotechnology industry value: $ billion(e)
Figure: Canada biotechnology industry category segmentation: % share, by value, (e)
Figure: Canada biotechnology industry geography segmentation: % share, by value, (e)
Figure: Canada biotechnology industry value forecast: $ billion
Figure: Forces driving competition in the biotechnology industry in Canada,
Figure: Drivers of buyer power in the biotechnology industry in Canada,
Figure: Drivers of supplier power in the biotechnology industry in Canada,
Figure: Factors influencing the likelihood of new entrants in the biotechnology industry in Canada,
Figure: Factors influencing the threat of substitutes in the biotechnology industry in Canada,
Figure: Drivers of degree of rivalry in the biotechnology industry in Canada,
Figure: Amgen, Inc.: revenues & profitability
Figure: Amgen, Inc.: assets & liabilities
Figure: Baxter International Inc.: revenues & profitability
Figure: Baxter International Inc.: assets & liabilities
Figure: Covance Inc.: revenues & profitability
Figure: Covance Inc.: assets & liabilities
Figure: Novartis AG: revenues & profitability
Figure: Novartis AG: assets & liabilities

Skip to top


Bladder Cancer Therapeutics: Market Research Report US$ 3,950.00 Oct, 2010 · 580 pages
Lymphoma Therapeutics: Market Research Report US$ 3,950.00 Apr, 2010 · 752 pages

Ask Your Question

Biotechnology in Canada
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: